Skip to content
healthcare.dev

Nelarabine

NDC 25021-259, Nelarabine, injection, solution, from Sagent Pharmaceuticals.

Product NDC
25021-259
Status
Listed
Labeler
Sagent Pharmaceuticals
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA212605
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/25021-259 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NELARABINE5 mg/mL

Pharmacologic classes

Nucleic Acid Synthesis Inhibitors [MoA]; Nucleoside Metabolic Inhibitor [EPC]

Package NDCNDC-11Package
25021-259-50250210259501 VIAL in 1 CARTON (25021-259-50) / 50 mL in 1 VIAL
25021-259-51250210259516 VIAL in 1 CARTON (25021-259-51) / 50 mL in 1 VIAL

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/f60da70f-2f9e-421d-a277-95b1edb57a71
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=25021-259

Use it

Look up 25021-259 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/25021-259 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 25021-259. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.